MAPT and Alzheimer disease: In our current experiments, we used human neural stem cells (HuCNS‐SC), derived from donated fetal brain tissue, to test the hypothesis that human NSC transplantation can improve the cognitive decline in AD models that exhibit either Aβ and tau pathology or neuronal loss.